● Recruiting

Cohort Study Evaluating Glycaemic Control in Individuals with Type 2 Diabetes Mellitus Through Digital Therapeutics (DM DTx)

Condition: Type 2 Diabetes Mellitus (T2DM) · Sponsor: EVYD Technology

PhaseNA

Planned participants500

Who can joinAll sexes, 18 Years to 70 Years

Healthy volunteersNo

About this study

This study is conducted to evaluate the effectiveness of Digital therapeutics (DTx) in managing patients with Type 2 Diabetes Mellitus (T2DM) by delivering digital lifestyle interventions through a national health application (BruHealth).

This description comes directly from the study's public registry record.

Talk to the study team

Jane Tey, Msc Immunology · +673 7430790 · jane.tey@evydtech.com

Joshua Lam, MBBS · +65 97309276 · joshua.lam@evydtech.com

Always discuss trial participation with your own doctor first.

Locations (1)

EVYD Technology

Bandar Seri Begawan, Brunei

Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06810986